Riding
It develops AI-enabled prescribing technology for cash-pay clinics responding to rising GLP-1 medication demand.
Overview
Riding is associated with technology for overhauling cash-pay clinic prescribing, with the funding context highlighting demand tied to GLP-1 medications. The company appears focused on clinics operating outside traditional reimbursement models, where prescribing workflows and patient access are core operational needs. The company has raised $8 million across one undisclosed round dated March 25, 2026. Its differentiation is framed around serving cash-pay clinic prescribing in a market shaped by rapid growth in GLP-1 treatments.
Funding History
Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing
Frequently Asked Questions
- How much funding does AI Funding track for Riding?
- AI Funding tracks $8M for Riding across 1 funding round in this database.
- What does Riding do?
- Riding is associated with technology for overhauling cash-pay clinic prescribing, with the funding context highlighting demand tied to GLP-1 medications. The company appears focused on clinics operating outside traditional reimbursement models, where prescribing workflows and patient access are core operational needs. The company has raised $8 million across one undisclosed round dated March 25, 2026. Its differentiation is framed around serving cash-pay clinic prescribing in a market shaped by rapid growth in GLP-1 treatments.
- Where is Riding headquartered?
- Riding is headquartered in San Francisco, CA.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.